Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis

被引:32
|
作者
Doig, Andrew J. [1 ]
机构
[1] Univ Manchester, Sch Biol Sci, Fac Biol Med & Hlth, Div Neurosci & Expt Psychol, Oxford Rd, Manchester M13 9PT, Lancs, England
基金
英国生物技术与生命科学研究理事会;
关键词
Aggregation; amyloid; amyloid-beta protein precursor; directed acyclic graph; drug discovery; peptide; systems biology; AMYLOID-BETA-PEPTIDE; MILD COGNITIVE IMPAIRMENT; SIMPLEX-VIRUS TYPE-1; A-BETA; OXIDATIVE STRESS; ANTIINFLAMMATORY DRUGS; LIPID-PEROXIDATION; PRECURSOR PROTEIN; BRAIN; OXYSTEROLS;
D O I
10.3233/JAD-180583
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The dominant model for Alzheimer's disease (AD) is the amyloid cascade hypothesis, in which the accumulation of excess amyloid-beta (A beta) leads to inflammation, excess glutamate and intracellular calcium, oxidative stress, tau hyperphosphorylation and tangle formation, neuronal loss, and ultimately dementia. In a cascade, AD proceeds in a unidirectional fashion, with events only affecting downstream processes. Compelling evidence now exists for the presence of positive feedback loops in AD, however, involving oxidative stress, inflammation, glutamate, calcium, and tau. The pathological state of AD is thus a system of positive feedback loops, leading to amplification of the initial perturbation, rather than a linear cascade. Drugs may therefore be effective by targeting numerous points within the loops, rather than concentrating on upstream processes. Anti-inflammatories and anti-oxidants may be especially valuable, since these processes are involved in many loops and hence would affect numerous processes in AD.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 50 条
  • [1] A positive-feedback model for the loss of acetylcholine in Alzheimer's disease
    Ehrenstein, G
    Galdzicki, Z
    Lange, GD
    REACTIVE OXYGEN SPECIES: FROM RADIATION TO MOLECULAR BIOLOGY: A FESTSCHRIFT IN HONOR OF DANIEL L GILBERT, 2000, 899 : 283 - 291
  • [2] Enhanced Feedback-Related Negativity in Alzheimer's Disease
    Nitta, Eri
    Onoda, Keiichi
    Ishitobi, Fuminori
    Okazaki, Ryota
    Mishima, Seiji
    Nagai, Atsushi
    Yamaguchi, Shuhei
    FRONTIERS IN HUMAN NEUROSCIENCE, 2017, 11
  • [3] The endotoxin hypothesis of Alzheimer’s disease
    Guy C. Brown
    Michael T. Heneka
    Molecular Neurodegeneration, 19
  • [4] Alzheimer's disease: A hypothesis on pathogenesis
    Harman, D
    JOURNAL OF THE AMERICAN AGING ASSOCIATION, 2000, 23 (03) : 147 - 161
  • [5] A hypothesis on the pathogenesis of Alzheimer's disease
    Harman, D
    PHARMACOLOGICAL INTERVENTION IN AGING AND AGE-ASSOCIATED DISORDERS: PROCEEDINGS OF THE SIXTH CONGRESS OF THE INTERNATIONAL ASSOCIATION OF BIOMEDICAL GERONTOLOGY, 1996, 786 : 152 - 168
  • [6] Lipofuscin Hypothesis of Alzheimer's Disease
    Giaccone, Giorgio
    Orsi, Laura
    Cupidi, Chiara
    Tagliavini, Fabrizio
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA, 2011, 1 (01): : 292 - 296
  • [7] Alzheimer's disease: A hypothesis on pathogenesis
    Harman D.
    Journal of the American Aging Association, 2000, 23 (3) : 147 - 161
  • [8] Calcium hypothesis of Alzheimer’s disease
    Michael J. Berridge
    Pflügers Archiv - European Journal of Physiology, 2010, 459 : 441 - 449
  • [9] Calcium hypothesis of Alzheimer's disease
    Berridge, Michael J.
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2010, 459 (03): : 441 - 449
  • [10] The endotoxin hypothesis of Alzheimer's disease
    Brown, Guy C.
    Heneka, Michael T.
    MOLECULAR NEURODEGENERATION, 2024, 19 (01)